个性化新生儿治疗:在治疗孤儿群体中应用主管配方
Wenwen Shao1, Angela Gomez2, Alejandra Alejano1
1Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.
Pharmaceutics
|August 28, 2025
概括
对于缺乏经批准的治疗方法的新生儿来说, 大师配方 (MF) 提供了潜在的解决方案. 这一审查强调了儿童药物开发的挑战以及需要更好的,基于证据的新生儿药物.
科学领域:
- 新生儿药理学
- 儿童药物配方
- 基于证据的医学
背景情况:
- 对新生儿的批准治疗方法的有限可用性.
- 新生儿和成年人之间的生理差异使药物配方复杂化.
- 儿科研究的挑战包括少数临床试验和非标签药物使用.
研究的目的:
- 作为新生儿的治疗选择,探索大师配方 (MF).
- 分析新生儿MF的药物形式,适用情况和剂量建议.
- 解决新生儿药物短缺问题.
主要方法:
- 对新生儿药物的科学文献的审查.
- 分析儿科中常用的大师配方,特别是对于新生儿.
- 按治疗组分类药物 (抗高血压药,皮质类固醇,抗药).
主要成果:
- 新生儿经常在新生儿重症监护室和初级卫生保健中接受非标签药物.
- 药剂师经常为儿科使用准备Magistral配方.
- 新生儿和成年人之间存在显著的药理动力学差异.
结论:
- 有必要促进针对新生儿的儿童药物设计的研究和开发.
- 适合年龄的剂量形式和改善的药物信息是必不可少的.
- 解决批准的新生儿药物短缺需要扩大研究和监管支持.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.5K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Dosage Regimen: Individualization
388
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
388
Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
960
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960
Pharmacokinetics in Pediatric Patients: Drug Distribution
552
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Drug Excretion
404
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404


